Establishment Labs

Establishment Labs (NASDAQ: ESTA) is a global medical technology company dedicated to enhancing patient safety and aesthetic outcomes in breast reconstruction and aesthetics. The company specializes in designing, developing, manufacturing, and marketing its flagship silicone gel-filled breast implants, Motiva Implants, which form the core of the MotivaImagine platform. Motiva Implants are produced in FDA-compliant facilities in Costa Rica and are distributed in more than 70 countries through exclusive partners and a direct sales force. With FDA approval for a clinical trial in the United States, Establishment Labs demonstrates a commitment to rigorous clinical validation and market-leading innovation.